Novogen Limited Early Study Provides Evidence That Investigational Drug Phenoxodiol Targets Prostate Cancer Protein

September 18, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

STAMFORD, Conn. and SYDNEY, Australia, Sept. 18 /PRNewswire-FirstCall/ -- Novogen Limited's subsidiary, Marshall Edwards, Inc. (Nasdaq: MSHL - News; London AIM: MSH) has just made the following announcement.

Twitter
LinkedIn
Facebook
Email
Print

Australia